Ong V - Search Results

1

Consensus best practice pathway of the UK Systemic Sclerosis Study group: management of cardiac disease in systemic sclerosis.

Bissell LA, Anderson M, Burgess M, Chakravarty K, Coghlan G, Dumitru RB, Graham L, Ong V, Pauling JD, Plein S, Schlosshan D, Woolfson P, Buch MH. Bissell LA, et al. Among authors: ong v. Rheumatology (Oxford). 2017 Jun 1;56(6):912-921. doi: 10.1093/rheumatology/kew488. Rheumatology (Oxford). 2017. PMID: 28160468 Free article.

2

Management of systemic sclerosis.

Ong VH, Brough G, Denton CP. Ong VH, et al. Clin Med (Lond). 2005 May-Jun;5(3):214-9. doi: 10.7861/clinmedicine.5-3-214. Clin Med (Lond). 2005. PMID: 16011210 Free PMC article. Review. No abstract available.

3

Innovative therapies for systemic sclerosis.

Ong VH, Denton CP. Ong VH, et al. Curr Opin Rheumatol. 2010 May;22(3):264-72. doi: 10.1097/BOR.0b013e328337c3d6. Curr Opin Rheumatol. 2010. PMID: 20190640 Review.

4

Clinical and serological hallmarks of systemic sclerosis overlap syndromes.

Pakozdi A, Nihtyanova S, Moinzadeh P, Ong VH, Black CM, Denton CP. Pakozdi A, et al. J Rheumatol. 2011 Nov;38(11):2406-9. doi: 10.3899/jrheum.101248. Epub 2011 Aug 15. J Rheumatol. 2011. PMID: 21844148

5

Targeted therapies for systemic sclerosis.

Denton CP, Ong VH. Denton CP, et al. Nat Rev Rheumatol. 2013 Aug;9(8):451-64. doi: 10.1038/nrrheum.2013.46. Epub 2013 Apr 9. Nat Rev Rheumatol. 2013. PMID: 23567456 Review.

6

Targeting the endothelin axis in scleroderma renal crisis: rationale and feasibility.

Penn H, Quillinan N, Khan K, Chakravarty K, Ong VH, Burns A, Denton CP. Penn H, et al. Among authors: ong vh. QJM. 2013 Sep;106(9):839-48. doi: 10.1093/qjmed/hct111. Epub 2013 May 21. QJM. 2013. PMID: 23696678

7

Prediction of pulmonary complications and long-term survival in systemic sclerosis.

Nihtyanova SI, Schreiber BE, Ong VH, Rosenberg D, Moinzadeh P, Coghlan JG, Wells AU, Denton CP. Nihtyanova SI, et al. Arthritis Rheumatol. 2014 Jun;66(6):1625-35. doi: 10.1002/art.38390. Arthritis Rheumatol. 2014. PMID: 24591477

8

Current management strategies for systemic sclerosis.

Nihtyanova SI, Ong VH, Denton CP. Nihtyanova SI, et al. Clin Exp Rheumatol. 2014 Mar-Apr;32(2 Suppl 81):156-64. Epub 2014 Apr 11. Clin Exp Rheumatol. 2014. PMID: 24742450 Review.

9

Consensus best practice pathway of the UK scleroderma study group: gastrointestinal manifestations of systemic sclerosis.

Hansi N, Thoua N, Carulli M, Chakravarty K, Lal S, Smyth A, Herrick A, Ogunbiyi O, Shaffer J, Mclaughlin J, Denton C, Ong V, Emmanuel AV, Murray CD. Hansi N, et al. Among authors: ong v. Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-214-21. Epub 2014 Nov 5. Clin Exp Rheumatol. 2014. PMID: 25372804 Review.

10

Consensus best practice pathway of the UK Scleroderma Study Group: digital vasculopathy in systemic sclerosis.

Hughes M, Ong VH, Anderson ME, Hall F, Moinzadeh P, Griffiths B, Baildam E, Denton CP, Herrick AL. Hughes M, et al. Rheumatology (Oxford). 2015 Nov;54(11):2015-24. doi: 10.1093/rheumatology/kev201. Epub 2015 Jun 26. Rheumatology (Oxford). 2015. PMID: 26116156 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

239 results

Search Page